Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
RENX.L Stock Summary
In the News
RENX.L Financial details
Company Rating
Sell
Market Cap
35.48M
Income
-43.81M
Revenue
2.89M
Book val./share
-0.02
Cash/share
0.15
Dividend
-
Dividend %
-
Employees
102
Optionable
No
Shortable
Yes
Earnings
15 Feb 2024
P/E
-0.43
Forward P/E
-279.17
PEG
0.09
P/S
7.57
P/B
-12.66
P/C
223.33
P/FCF
-0.07
Quick Ratio
0.92
Current Ratio
1.09
Debt / Equity
-7.08
LT Debt / Equity
-3.93
-
-
EPS (TTM)
-0.39
EPS next Y
-0.12
EPS next Q
-0.04
EPS this Y
-28.21%
EPS next Y
-70.46%
EPS next 5Y
-155.17%
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-11.39%
EPS Q/Q
2400%
-
-
-
-
SMA20
13.33%
SMA50
161.54%
SMA100
-17.07%
Inst Own
0.24%
Inst Trans
0.79%
ROA
-224%
ROE
-540%
ROC
-9.02%
Gross Margin
14%
Oper. Margin
-1361%
Profit Margin
-1514%
Payout
-2743%
Shs Outstand
99.93M
Shs Float
66.03M
-
-
-
-
Target Price
-
52W Range
10.0-150.0
52W High
-77.67%
52W Low
+235%
RSI
52
Rel Volume
0.14
Avg Volume
718.53K
Volume
100.76K
Perf Week
-5.63%
Perf Month
4.69%
Perf Quarter
-29.47%
Perf Half Y
-59.39%
-
-
-
-
Beta
1.922
-
-
Volatility
0.91%, 6.06%
Prev Close
-2.5%
Price
33.5
Change
-3.79%
RENX.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-30
Metric | History | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 22.2 | 0.02 | 0.04 | 0.04 | |
Net income per share | -0.15 | 2.4 | -0.43 | -0.78 | -0.56 | |
Operating cash flow per share | -0.11 | 0 | -0.34 | -0.63 | -0.4 | |
Free cash flow per share | -0.46 | 0 | -0.37 | -0.64 | -0.41 | |
Cash per share | 25.87 | 0.01 | 1.04 | 0.6 | 0.32 | |
Book value per share | 0.75 | 0.01 | 1.33 | 0.59 | 0.22 | |
Tangible book value per share | -531.86 | -7.71 | -322.62 | -317.18 | -281.4 | |
Share holders equity per share | 0.75 | 0.01 | 1.33 | 0.59 | 0.22 | |
Interest debt per share | 660.8 | 0.23 | 0 | 0.17 | 0.15 | |
Market cap | 133.74M | 15.44B | 896.4M | 88.71M | 107.34M | |
Enterprise value | 124.45M | 15.42B | 831.59M | 60.09M | 94.81M | |
P/E ratio | -24.06 | 2.45 | -28.91 | -1.56 | -2.32 | |
Price to sales ratio | 0 | 0.26 | 601.21 | 29.87 | 31.54 | |
POCF ratio | -33.49 | -1.53K | -36.39 | -1.94 | -3.29 | |
PFCF ratio | -7.85 | -1.36K | -34.13 | -1.91 | -3.22 | |
P/B Ratio | 4.75 | 429.21 | 9.43 | 2.06 | 5.82 | |
PTB ratio | 4.75 | 429.21 | 9.43 | 2.06 | 5.82 | |
EV to sales | 0 | 0.26 | 557.74 | 20.23 | 27.86 | |
Enterprise value over EBITDA | -23.16 | 1.16 | -21.1 | -1.33 | -2.67 | |
EV to operating cash flow | -31.16 | -1.53K | -33.76 | -1.31 | -2.9 | |
EV to free cash flow | -7.3 | -1.36K | -31.67 | -1.29 | -2.84 | |
Earnings yield | -0.04 | 0.41 | -0.03 | -0.64 | -0.43 | |
Free cash flow yield | -0.13 | 0 | -0.03 | -0.52 | -0.31 | |
Debt to equity | 875.83 | 0.02 | 0 | 0.29 | 0.66 | |
Debt to assets | 852.97 | 0.02 | 0 | 0.2 | 0.29 | |
Net debt to EBITDA | 1.73 | 0 | 1.64 | 0.63 | 0.35 | |
Current ratio | 12.45 | 5.59 | 10.46 | 3.89 | 1.76 | |
Interest coverage | -326.85 | 18.4 | -10.87K | -28.69K | -21.18K | |
Income quality | 0.61 | 0.95 | 0.69 | 0.92 | 0.71 | |
Dividend Yield | 34.83 | 0.31 | 5.83 | 57.52 | 43.18 | |
Payout ratio | -837.93 | 0.75 | -168.57 | -89.94 | -100.28 | |
Sales general and administrative to revenue | 0 | 0 | 5.62 | 4.36 | 12.65 | |
Research and developement to revenue | 0 | 0.02 | 6.73 | 4.93 | 4.2 | |
Intangibles to total assets | 0.63 | 0.41 | 0.18 | 0.22 | 0.3 | |
Capex to operating cash flow | 3.27 | 0.13 | 0.07 | 0.02 | 0.02 | |
Capex to revenue | 0 | 0 | -1.09 | -0.23 | -0.2 | |
Capex to depreciation | -11.6 | 2.71 | -0.78 | -0.27 | -0.28 | |
Stock based compensation to revenue | 0 | 0 | 1.46 | 2.36 | 0.46 | |
Graham number | 1.59 | 0.86 | 3.6 | 3.22 | 1.69 | |
ROIC | 0 | 218.86 | -0.3 | -1.17 | -1.37 | |
Return on tangible assets | -0.52 | 260.94 | -0.37 | -1.15 | -1.56 | |
Graham Net | -7.14 | 0 | 0.94 | 0.36 | 0.04 | |
Working capital | 8.64M | 15.51M | 68.74M | 35.23M | 12.2M | |
Tangible asset value | 9.88M | 18.84M | 77.08M | 29.15M | 5.94M | |
Net current asset value | 8.64M | 13.56M | 68.53M | 27.34M | 4.67M | |
Invested capital | 875.83 | 0.02 | 0 | 0.29 | 0.66 | |
Average receivables | -2.46B | -2.46B | 18K | 1.11M | 1.55M | |
Average payables | 377.5K | 1.83M | 2.33M | 2.11M | 6.99M | |
Average inventory | 2.46B | 2.46B | 339.5K | 756.5K | 939K | |
Days sales outstanding | 0 | 0 | 4.41 | 269.76 | 97.39 | |
Days payables outstanding | 0 | 0.03 | 801.27 | 437.57 | 1.56K | |
Days of inventory on hand | 0 | 0 | 160.25 | 206.34 | 96.99 | |
Receivables turnover | 0 | 3.24M | 82.83 | 1.35 | 3.75 | |
Payables turnover | 0 | 11.26K | 0.46 | 0.83 | 0.23 | |
Inventory turnover | 0 | 100.13K | 2.28 | 1.77 | 3.76 | |
ROE | -0.2 | 175.45 | -0.33 | -1.31 | -2.5 | |
Capex per share | -0.35 | 0 | -0.02 | -0.01 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q1
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.01 | 0.02 | 0.01 | 0 | 0 | |
Net income per share | -0.16 | -0.14 | -0.14 | 0 | -0.11 | |
Operating cash flow per share | -0.1 | -0.11 | -0.12 | 0 | -0.1 | |
Free cash flow per share | -0.1 | -0.11 | -0.12 | -0.12 | -0.1 | |
Cash per share | 0.41 | 0.34 | 0.39 | 0.32 | 0.15 | |
Book value per share | 0.25 | 0.12 | 0.21 | 0 | -0.02 | |
Tangible book value per share | 0.25 | -0.05 | 0.21 | -17.2 | -0.03 | |
Share holders equity per share | 0.25 | 0.12 | 0.21 | 0 | -0.02 | |
Interest debt per share | 0.15 | 0.16 | 0.14 | 0.07 | 0.11 | |
Market cap | 50.14M | 61.32M | 82.59M | 3.31B | 66.11M | |
Enterprise value | 30.24M | 49.71M | 61.18M | 3.3B | 62.78M | |
P/E ratio | -1.05 | -1.47 | -1.71 | -74.5 | -1.63 | |
Price to sales ratio | 51.74 | 51.45 | 114.07 | 6.39K | 144.04 | |
POCF ratio | -7.04 | -7.45 | -8.18 | -383.29 | -6.96 | |
PFCF ratio | -7.04 | -7.45 | -8.18 | -10.76 | -6.96 | |
P/B Ratio | 2.66 | 6.9 | 4.56 | 474.95 | -44.34 | |
PTB ratio | 2.66 | 6.9 | 4.56 | 474.95 | -44.34 | |
EV to sales | 31.2 | 41.71 | 84.51 | 6.36K | 136.77 | |
Enterprise value over EBITDA | -3.17 | -5.69 | -6.19 | -392.76 | -8.83 | |
EV to operating cash flow | -4.25 | -6.04 | -6.06 | -381.84 | -6.61 | |
EV to free cash flow | -4.25 | -6.04 | -6.06 | -10.72 | -6.61 | |
Earnings yield | -0.24 | -0.17 | -0.15 | 0 | -0.15 | |
Free cash flow yield | -0.14 | -0.13 | -0.12 | -0.09 | -0.14 | |
Debt to equity | 0.59 | 1.37 | 0.64 | 1.74 | -7.08 | |
Debt to assets | 0.29 | 0.4 | 0.29 | 0.4 | 0.54 | |
Net debt to EBITDA | 2.09 | 1.33 | 2.17 | 1.5 | 0.47 | |
Current ratio | 2.58 | 1.86 | 2.43 | 1.67 | 1.09 | |
Interest coverage | 0 | 0 | 0 | -0.06 | 0 | |
Income quality | 0.6 | 0.79 | 0.83 | 0.78 | 0.94 | |
Dividend Yield | 0 | 0 | 0 | 0.36 | 0 | |
Payout ratio | 0 | 0 | 0 | -108.2 | 0 | |
Sales general and administrative to revenue | 8.51 | 5.71 | 9.8 | 12.56 | 13.2 | |
Research and developement to revenue | 3.88 | 2.79 | 5.45 | 6.32 | 6.07 | |
Intangibles to total assets | 0 | 0.42 | 0 | 1.42K | 0.05 | |
Capex to operating cash flow | 0 | 0 | 0 | 34.63 | 0 | |
Capex to revenue | 0 | 0 | 0 | -577.21 | 0 | |
Capex to depreciation | 0 | 0 | 0 | -2.49K | 0 | |
Stock based compensation to revenue | 0.79 | 0.69 | 1.07 | 1.11 | 1.14 | |
Graham number | 0.95 | 0.61 | 0.82 | 0.02 | 0.19 | |
ROIC | -0.39 | -0.49 | -0.36 | -0.52 | -1.12 | |
Return on tangible assets | -0.31 | -0.59 | -0.3 | 0 | -0.55 | |
Graham Net | 0.15 | 0.05 | 0.13 | -0.3 | -0.08 | |
Working capital | 21.09M | 12.31M | 21.04M | 10.75M | 1.3M | |
Tangible asset value | 18.84M | -4.11M | 18.1M | -43.6B | -2.47M | |
Net current asset value | 14.56M | 4.83M | 14.02M | 3.22M | -4.56M | |
Invested capital | 0.59 | 1.37 | 0.64 | 1.74 | -7.08 | |
Average receivables | 1.34M | 0 | 0 | -3.09B | -3.09B | |
Average payables | 5.77M | 4.21M | 3.67M | 3.07M | 3.15M | |
Average inventory | 580K | 458.5K | 458.5K | 3.09B | 3.09B | |
Days sales outstanding | 0 | 0 | 0 | -1.07M | 0 | |
Days payables outstanding | 551.12 | 525.06 | 477.46 | 392.63 | 603.82 | |
Days of inventory on hand | 0 | 116.08 | 0 | 827.13K | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0.16 | 0.17 | 0.19 | 0.23 | 0.15 | |
Inventory turnover | 0 | 0.78 | 0 | 0 | 0 | |
ROE | -0.63 | -1.18 | -0.67 | -1.59 | 6.81 | |
Capex per share | 0 | 0 | 0 | -0.12 | 0 |
RENX.L Frequently Asked Questions
What is Renalytix Plc stock symbol ?
Renalytix Plc is a US stock , located in New york of Ny and trading under the symbol RENX.L
What is Renalytix Plc stock quote today ?
Renalytix Plc stock price is $33.5 today.
Is Renalytix Plc stock public?
Yes, Renalytix Plc is a publicly traded company.